Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
DB-1311 by BioNTech for Solid Tumor: Likelihood of Approval
DB-1311 is under clinical development by BioNTech and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...
DB-1311 by BioNTech for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Likelihood of Approval
DB-1311 is under clinical development by BioNTech and currently in Phase II for Metastatic Castration-Resistant Prostate Cancer (mCRPC). According to...
DB-1311 by BioNTech for Non-Small Cell Lung Cancer: Likelihood of Approval
DB-1311 is under clinical development by BioNTech and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...